The role of the Hippo pathway in autophagy in the heart. Issue 17 (12th February 2022)

• Record Type: Journal Article
• Authors: Maejima, Yasuhiro; Zablocki, Daniela; Nah, Jihoon; Sadoshima, Junichi
• Is Part Of: Cardiovascular research. Volume 118:Issue 17(2022)
• Page Start: 3320
• Page End: 3330
• Publication Date: 2022-02-12
• Subjects: Hippo pathway -- Autophagy -- Mst1 -- YAP -- Heart; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Periodicals; 616.1
• DOI: 10.1093/cvr/cvac014
• Languages: English
• ISSNs: 0008-6363

Abstract

Abstract: The Hippo pathway, an evolutionarily conserved signalling mechanism, controls organ size and tumourigenesis. Increasing lines of evidence suggest that autophagy, an important mechanism of lysosome-mediated cellular degradation, is regulated by the Hippo pathway, which thereby profoundly affects cell growth and death responses in various cell types. In the heart, Mst1, an upstream component of the Hippo pathway, not only induces apoptosis but also inhibits autophagy through phosphorylation of Beclin 1. YAP/TAZ, transcription factor co-factors and the terminal effectors of the Hippo pathway, affect autophagy through transcriptional activation of TFEB, a master regulator of autophagy and lysosomal biogenesis. The cellular abundance of YAP is negatively regulated by autophagy and suppression of autophagy induces accumulation of YAP, which, in turn, acts as a feedback mechanism to induce autophagosome formation. Thus, the Hippo pathway and autophagy regulate each other, thereby profoundly affecting cardiomyocyte survival and death. This review discusses the interaction between the Hippo pathway and autophagy and its functional significance during stress conditions in the heart and the cardiomyocytes therein. Graphical Abstract: